Loading…

PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers. In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 1997-03, Vol.275 (5308), p.1943-1947
Main Authors: Li, Jing, Yen, Clifford, Liaw, Danny, Podsypanina, Katrina, Bose, Shikha, Wang, Steven I., Puc, Janusz, Miliaresis, Christa, Rodgers, Linda, McCombie, Richard, Bigner, Sandra H., Giovanella, Beppino C., Ittmann, Michael, Tycko, Ben, Hibshoosh, Hanina, Wigler, Michael H., Parsons, Ramon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers. In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas. The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin, a protein that interacts with actin filaments at focal adhesions. These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.
ISSN:0036-8075
1095-9203
DOI:10.1126/science.275.5308.1943